"For the millions of people who suffer from atopic dermatitis (AD), or eczema, ENS-002 represents a potential paradigm ... a promising step forward not only in managing a challenging skin condition ...

Therefore, even individuals without childhood eczema may experience it later in life. Dr Grant has debunked the common ...

There are lots of misconceptions around eczema, from poor hygiene to the skin condition disappearing on its own - there is a ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

An Auckland-based artist living with debilitating symptoms of topical steroid withdrawal (TSW) believes his dermatologists ...

For many, fall is their favourite time of year. The bugs are gone, the leaves are turning colours and the holidays are on the ...

A study found that people who live in places with high levels of air pollution are more likely to have eczema.

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

Dermatologists have warned that applying adult skincare products and alcohol-based creams on babies puts them at risk of skin ...

Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research shows.

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

About Atopic Dermatitis Atopic Dermatitis (AD), a form of eczema, is a chronic inflammatory skin condition characterized by areas of dry skin that are red and intensely itchy. Rigorous moisturizing ...